Plasma as a constituent is the remaining part of the blood after the extraction of red blood cells, white blood cells. It is responsible in transporting nutrients, enzymes, hormones, and proteins to various part of the body. Plasma holds important properties, important characters which are responsible for the manufacturing of life saving proteins of clinical significance. There are important factors which can be extracted from the plasma, include albumin, FVII, IVIG that are now better adjusted and known as plasma-derived drugs for severe health conditions.
Plasma-Derived Drugs Market: Drivers and Restraints
The cost of manufacturing plasma-derived drugs is more than four times the cost of manufacturing other pharmaceuticals. The business model for plasma-derived drugs is different than what is present in the pharmaceutical market. The clear cut research process and drug discovery process is different, more over the industry requires a more vigorous approach in order to create a balance in the sales. Manufacturers of the plasma-derived drugs spend the majority of their resources on manufacturing each drug. There are threats present in developing plasma-derived drugs, threats of emerging pathogens have a great effect on the production cost for each manufacturer in the plasma-derived drugs market. The manufacturing of plasma-derived drugs takes a significant time, it could go from eight months to more than twelve months, and any shortcomings in the period can create serious consequences for the company affecting the market dynamics. The more important characteristics present for the plasma-derived drugs market revolves around the government policies present to increase the number of blood banks. Plasma policies aims to make the availability, accessibility of plasma to a greater extend. The aim is to move the available adequate amount of plasma throughout different corners for better use.
Plasma-Derived Drugs Market: Overview
The global market for plasma-derived drugs is estimated to experience a significant growth during the forecast period. The increase in incidence of rare and chronic diseases creates a more lucrative opportunity for manufactures present in the market. The current structure of the plasma-derived drugs market include immunoglobulin products, albumin products, clotting factors and few others. Each of the plasma-derived drugs uses different type of mechanism and are used to deliver better clinical results.
Plasma-Derived Drugs Market: Regional Wise Outlook
Geographically, the Plasma-Derived Drugs market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. Each country is equally important to drive the market for plasma-derived drugs, advanced or emerging healthcare settings help in restoring the market and increase the reach to a wider section of patients in need. Blood donation is an important part for plasma-derived drugs, the more number of blood units would result in more number of such products. The developed economies play an important role in the industry but emerging economies are also moving at a good pace. The North America region is estimated to have a significant share in the plasma-derived drugs market, owing to its quality infrastructure supporting the need of plasma-derived drugs. They are followed by Europe, East Asia and Oceania. The South Asia plasma-derived drugs market would translate as a lucrative market opportunity for manufacturers, as well as industry experts, with present change in adoption and growth in general pharmaceutical market.
The involved in the market of plasma-derived drugs include Grifols, S.A., Octa Pharma, Antaris Pharma, CSL Limited. The present market structure of plasma-derived drugs is expected to change with efforts and research present in clinical phase.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology Matrix
- Value Chain
Regional analysis of the Plasma-Derived Drugs market report includes
- North America
- Latin America
- South Asia
- East Asia
- Middle East and Africa
Plasma-Derived Drugs Market: Segmentation
Tentatively, the global plasma-derived drugs market has been segmented on the basis of product type, end user and geography.
Based on product type, the global plasma-derived drugs market is segmented as:
- Clotting factors
Based on end user, the global plasma-derived drugs market is segmented as:
- Ambulatory Surgical Centers
- Specialty Clinic
- Home care setting
- Overview of Global Healthcare Market
- Evolution of the technology
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.